Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone

Completed · Phase 3

Conditions studied: Type 2 Diabetes, Obesity

In brief

The purpose of the study is to investigate the effectiveness of three lifestyle treatment programs varying in level of intensiveness on prevention of pioglitazone-induced weight gain and to measure the composition of the change in body weight.

Key facts

Study ID

NCT00737347

Run by

Northwestern University

People needed

39

Starts

2003-09-01

Expected to finish

2008-04-01

Last updated by the study team

2008-08-19

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• type 2 diabetes with BMI 27 or greater, glycated hemoglobin 7% or greater

You may not qualify if…

• insulin treated

Where it is running

• Northwestern Memorial Hospital Wellness Institute — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.